Beyond Traditional Growth-Studies: Using Developmental Biomarkers to Demonstrate Benefits & Safety
- Reframe the limits of the traditional growth-studies by demonstrating why weight and length alone are insufficient to show ingredient value and how developmental biomarkers can reveal meaningful biological effects earlier
- Show how emerging microbiome, metabolic, immune, and neurodevelopmental measurements enable shorter, more informative studies that de-risk innovation
- Highlight next-generation study approaches including omics and AI that support precision nutrition claims without requiring long-term IQ or obesity outcomes
- Equip innovators with practical examples of non-growth endpoints that can demonstrate developmental benefit, support regulatory conversations, and expand the evidence toolkit for infant formula ingredients